Literature DB >> 8622858

Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability.

J R Eshleman1, S D Markowitz, P S Donover, E Z Lang, J D Lutterbaugh, G M Li, M Longley, P Modrich, M L Veigl, W D Sedwick.   

Abstract

Colon cancer and an increasing number of other cancers have been found to exhibit instability of DNA microsatellite sequences. Such tumors have been designated as replication errors (RER) tumors. However, as microsatellites are only rarely found within coding regions of the genome, instability of these sequences cannot directly contribute to carcinogenesis. Recently, we have shown RER colon cancers also demonstrate a marked 100-fold increase in mutation rates measured within an expressed gene, hprt, suggesting the mutator phenotype in these tumors extends beyond microsatellite sequences. To determine whether the RER phenotype indeed destabilizes non-repetitive DNA sequences we have sequenced hprt gene mutations recovered from the RER colon cancer cell line RKO. Greater than 10% of hprt mutants proved to be a single 3 bp deletion located in a nonrepetitive ATTAT sequence motif. Additionally, 1-4 bp deletions or insertions were found to be randomly located throughout the hprt gene. Lastly, one third of hprt mutations proved to be transitions or transversions. The microsatellite instability demonstrated in RKO is thus a global mutator phenotype which destabilizes DNA sequences both inside and outside of repetitive sequence elements and which augments base substitutions as well as frameshifts. These findings extend the characteristics of mutations associated with RER tumors and suggest additional mechanisms by which mutator phenotypes may alter oncogenes and tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622858

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction.

Authors:  K D Berg; C L Glaser; R E Thompson; S R Hamilton; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.

Authors:  J Rüschoff; S Wallinger; W Dietmaier; T Bocker; G Brockhoff; F Hofstädter; R Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.

Authors:  Hagit Turm; Myriam Maoz; Vered Katz; Yong-Jun Yin; Steffan Offermanns; Rachel Bar-Shavit
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

4.  A model for random genetic damage directing selection of diploid or aneuploid tumours.

Authors:  P S Bazeley; A L Nestor Kalinoski; J A Ways; S-T Liu; R S Ramdath; S-i Matsui; D C Allison
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

5.  Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase proofreading yeast mutants.

Authors:  H T Tran; J D Keen; M Kricker; M A Resnick; D A Gordenin
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

6.  Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.

Authors:  T Fujiwara; J M Stolker; T Watanabe; A Rashid; P Longo; J R Eshleman; S Booker; H T Lynch; J R Jass; J S Green; H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

7.  Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability.

Authors:  A Baross-Francis; S E Andrew; J E Penney; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.

Authors:  Siân Jones; Meng Li; D Williams Parsons; Xiaosong Zhang; Jelle Wesseling; Petra Kristel; Marjanka K Schmidt; Sanford Markowitz; Hai Yan; Darell Bigner; Ralph H Hruban; James R Eshleman; Christine A Iacobuzio-Donahue; Michael Goggins; Anirban Maitra; Sami N Malek; Steve Powell; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Hum Mutat       Date:  2011-11-23       Impact factor: 4.878

9.  Nanopore sequencing detects structural variants in cancer.

Authors:  Alexis L Norris; Rachael E Workman; Yunfan Fan; James R Eshleman; Winston Timp
Journal:  Cancer Biol Ther       Date:  2016-01-19       Impact factor: 4.742

10.  A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents.

Authors:  A R Parker; C P Leonard; L Hua; R O Francis; S Dhara; A Maitra; J R Eshleman
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.